DE602004007302D1 - Verfahren zur herstellung von komprimierten festen dosierungsformen, das gut zur verwendung mit schlecht wasserlöslichen arzneistoffen geeignet ist, und danach hergestellte komprimierte feste dosierungsformen - Google Patents
Verfahren zur herstellung von komprimierten festen dosierungsformen, das gut zur verwendung mit schlecht wasserlöslichen arzneistoffen geeignet ist, und danach hergestellte komprimierte feste dosierungsformenInfo
- Publication number
- DE602004007302D1 DE602004007302D1 DE602004007302T DE602004007302T DE602004007302D1 DE 602004007302 D1 DE602004007302 D1 DE 602004007302D1 DE 602004007302 T DE602004007302 T DE 602004007302T DE 602004007302 T DE602004007302 T DE 602004007302T DE 602004007302 D1 DE602004007302 D1 DE 602004007302D1
- Authority
- DE
- Germany
- Prior art keywords
- dosage forms
- solid dosage
- compressed solid
- made therefrom
- bad water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2004/037462 WO2006052254A2 (en) | 2004-11-10 | 2004-11-10 | Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby |
Publications (2)
Publication Number | Publication Date |
---|---|
DE602004007302D1 true DE602004007302D1 (de) | 2007-08-09 |
DE602004007302T2 DE602004007302T2 (de) | 2008-03-20 |
Family
ID=36218312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004007302T Active DE602004007302T2 (de) | 2004-11-10 | 2004-11-10 | Verfahren zur herstellung von komprimierten festen dosierungsformen, das gut zur verwendung mit schlecht wasserlöslichen arzneistoffen geeignet ist, und danach hergestellte komprimierte feste dosierungsformen |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1729735B1 (de) |
JP (1) | JP4842960B2 (de) |
AT (1) | ATE365546T1 (de) |
AU (1) | AU2004324858B2 (de) |
CA (1) | CA2587295A1 (de) |
DE (1) | DE602004007302T2 (de) |
DK (1) | DK1729735T3 (de) |
HK (1) | HK1096875A1 (de) |
IL (2) | IL182549A (de) |
PT (1) | PT1729735E (de) |
WO (1) | WO2006052254A2 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2242483B1 (de) * | 2007-12-21 | 2013-02-20 | Synthon B.V. | Raloxifen-zusammensetzung |
US20110159084A1 (en) * | 2008-04-02 | 2011-06-30 | Dr. Reddy's Laboratories Ltd. | Raloxifene pharmaceutical formulations |
EP2448562B1 (de) | 2009-07-02 | 2013-11-06 | Synthon B.V. | Raloxifen-zusammensetzung |
EP3650010B1 (de) * | 2018-11-09 | 2021-01-06 | Siegfried AG | Verbesserter tablettierungsprozess |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
US5478847A (en) * | 1994-03-02 | 1995-12-26 | Eli Lilly And Company | Methods of use for inhibiting bone loss and lowering serum cholesterol |
AU701042B2 (en) * | 1995-02-28 | 1999-01-21 | Aventisub Llc | Pharmaceutical composition for piperidinoalkanol compounds |
IL115357A (en) * | 1995-09-20 | 2000-01-31 | Teva Pharma | Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols |
IL153441A0 (en) * | 2000-06-16 | 2003-07-06 | Teva Pharma | Stable gabapentin having ph within a controlled range |
AR029538A1 (es) * | 2000-07-06 | 2003-07-02 | Wyeth Corp | Composiciones farmaceuticas de agentes estrogenicos |
US20040185097A1 (en) * | 2003-01-31 | 2004-09-23 | Glenmark Pharmaceuticals Ltd. | Controlled release modifying complex and pharmaceutical compositions thereof |
-
2004
- 2004-11-10 AU AU2004324858A patent/AU2004324858B2/en not_active Expired - Fee Related
- 2004-11-10 DE DE602004007302T patent/DE602004007302T2/de active Active
- 2004-11-10 CA CA002587295A patent/CA2587295A1/en not_active Abandoned
- 2004-11-10 DK DK04810659T patent/DK1729735T3/da active
- 2004-11-10 AT AT04810659T patent/ATE365546T1/de not_active IP Right Cessation
- 2004-11-10 EP EP04810659A patent/EP1729735B1/de active Active
- 2004-11-10 PT PT04810659T patent/PT1729735E/pt unknown
- 2004-11-10 WO PCT/US2004/037462 patent/WO2006052254A2/en active Application Filing
- 2004-11-10 JP JP2007541148A patent/JP4842960B2/ja active Active
-
2007
- 2007-04-15 IL IL182549A patent/IL182549A/en active IP Right Grant
- 2007-04-27 HK HK07104564A patent/HK1096875A1/xx not_active IP Right Cessation
-
2009
- 2009-08-18 IL IL200447A patent/IL200447A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE602004007302T2 (de) | 2008-03-20 |
AU2004324858B2 (en) | 2009-12-10 |
JP2008519834A (ja) | 2008-06-12 |
HK1096875A1 (en) | 2007-06-15 |
EP1729735B1 (de) | 2007-06-27 |
IL182549A (en) | 2010-11-30 |
IL182549A0 (en) | 2007-09-20 |
EP1729735A2 (de) | 2006-12-13 |
DK1729735T3 (da) | 2007-10-08 |
JP4842960B2 (ja) | 2011-12-21 |
WO2006052254A2 (en) | 2006-05-18 |
WO2006052254A3 (en) | 2006-08-17 |
PT1729735E (pt) | 2007-08-06 |
CA2587295A1 (en) | 2006-05-18 |
ATE365546T1 (de) | 2007-07-15 |
AU2004324858A1 (en) | 2006-05-18 |
IL200447A0 (en) | 2011-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60120413T2 (de) | Quervernetzte stark amylose haltige stärke zur verwendung in pharmazeutischen formulierungen mit kontrollierter freisetzung und verfahren zu ihrer herstellung | |
ATE468111T1 (de) | Zusammensetzung in mikropellets mit kontrollierter freisetzung von physiologischen wirksubstanzen, verfahren zu ihrer herstellung und ihre verwendung im zootechnischen sektor | |
CN101965831B (zh) | 一种环保、缓释型防霉片及其制备方法 | |
WO2005039499A3 (en) | Rapidly disintegrating film | |
MXPA05005709A (es) | Composiciones farmaceuticas que comprenden un compuesto farmacologico basico respectivamente acido, un agente tensioactivo y un acido hidrosoluble fisiologicamente tolerable respectivamente base. | |
EP1476140A1 (de) | Geschmacksmaskierte film- oder oblatenförmige arzneizubereitung | |
CN109475504A (zh) | 剂型 | |
WO2011032912A1 (de) | Pharmazeutische zusammensetzung mit den wirkstoffen metformin und sitagliptin oder vildagliptin | |
CA2413698A1 (en) | Endoparasiticidal agents for voluntary oral ingestion by animals | |
GEP20115206B (en) | Novel piperidine carboxylic acid amide derivatives | |
HK1070821A1 (en) | Extended release venlafaxine tablet formulation | |
CN103429230A (zh) | 银杏提取物的控制释放片剂和其获得程序 | |
US20050256080A1 (en) | Method for reducing malodor of chondroitin | |
DE60306120D1 (de) | Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet | |
JP5038130B2 (ja) | 直接圧縮性リン酸三カルシウム | |
IL200447A0 (en) | Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby | |
MXPA04010121A (es) | Un metodo para estabilizar tabletas de clorhidrato de bupropion. | |
DE60111637D1 (de) | Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung | |
US5037658A (en) | Direct dry compressible acetaminophen composition | |
CN101912373B (zh) | 稳定的头孢克洛分散片及其制备方法 | |
CN100577152C (zh) | 一种氯沙坦钾氢氯噻嗪片及其制备方法 | |
RU2007133793A (ru) | Составы с контролируемым высвобождением альфузозина | |
KR101826994B1 (ko) | 제어된 방출성의 아스코르빈산 함유 경구용 정제 조성물 및 그 분석방법 | |
ATE285784T1 (de) | Pharmazeutische formulierung und ihre verwendung für die herstellung eines medikaments zur behandlung von herz-kreislauf-erkrankungen | |
RU2003108710A (ru) | Биологически активный стимулятор для птицеводства |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |